Dario investor rodman conference september 10 2013 (DRIO) Dr. Oren Fuerst
-
Upload
dr-oren-fuerst -
Category
Business
-
view
324 -
download
1
Transcript of Dario investor rodman conference september 10 2013 (DRIO) Dr. Oren Fuerst
Corporate Presentation September 2013 Dr. Oren Fuerst, Executive Chairman
נגטיב� לוגו
LabStyle Innovations Corp. (DRIO: OTCBB)Smart and Integrated Solutions for Diabetics in a Mobile Age
Thursday, September 12, 13
Subtitle text
Disclaimer Regarding Forward-Looking Statements This presentation of LabStyle Innovations Corp. (the “Company”) and statements of the Company’s management or agents related thereto contain or may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Act"). Words such as "seek," "intend," "believe," "plan," "estimate," "expect," "anticipate" and other similar expressions all denote forward-looking statements within the meaning of the Act. Factors that could cause or contribute to such differences include the Company’s compliance with regulatory requirements, the Company’s status as a new public company, the impact of current and any future competition, as well as other factors and risks discussed in the Company's filings with the U.S. Securities and Exchange Commission. Readers are cautioned that actual results may differ significantly from those set forth in the forward-looking statements. The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law. In addition, readers are cautioned that any estimates, forecasts or projections contained in this presentation or as may be discussed by Company management or its agents have been prepared by Company management in good faith on a basis believed to be reasonable. However, such estimates, forecasts and projections involve significant elements of subjective judgment and analysis and no representation can be made as to their attainability. No representation or warranty (express or implied) is made or is to be relied upon as a promise or representation as to the future performance of the Company. Readers are cautioned that such estimates, forecasts or projections have not been audited and have not been prepared in conformance with generally accepted accounting principles.
Thursday, September 12, 13
נגטיב� לוגו
Labstyle Innovations (DRIO:OTCBB) Corporate Snapshot
3
Delaware Company Founded 2011, based on IP from 2010Headquarters and Development (and IP) in Israel
-Share Price $2.65. Market Cap $53M (As of September 9, 2013)-Shares Outstanding 19.284M (Float ~ 11.5M shares)-Went public through S-1 in March 2013 -Raised $16M, including $10M in May 2013
נגטיב� לוגו
נגטיב� לוגו
Developer of Smart and Integrated Solutions for Diabetics in a Mobile Age
נגטיב� לוגו
Thursday, September 12, 13
4
Thursday, September 12, 13
נגטיב� לוגו
A large and growing global market5
2013 2022
$12b
$27b(Up 170%)370m
diabetics
20-30%insulin dependent
70-100mPrimary initial target users
Global glucose self-monitoring market
ObesityAging population
Thursday, September 12, 13
נגטיב� לוגו
Diabetes: A large and growing global market6
2011 2018
$37b
$72b
Global Diabetes (therapeutics devices and drugs) market
ObesityAging population
Text
2011 2030
10% CAGR
370m
550m
Number of Diabetics Worldwide
Source: Transparency Market Research, "Global Diabetes Devices Market and Diabetes Drugs Market - Industry Scenario, Trends, Analysis, Size, Share and Forecast, 2011 - 2018,"
Thursday, September 12, 13
נגטיב� לוגו
Glucose self-monitoring devices have not changed much over the past years
7
1990s 2000s
Thursday, September 12, 13
נגטיב� לוגו
A bulky device that is cumbersome to carry around with you
8
http://chocolateonmycranium.blogspot.com/2011/05/changes.html#.T8Yc05kthbo
Device
Lancer
Strips
Thursday, September 12, 13
נגטיב� לוגו
Uninspiring design9
Not aesthetically pleasing
Poor quality materials
They all look the same
Poor ergonomics
Thursday, September 12, 13
נגטיב� לוגו
Most data usability is lost after the measurement, no analysis and/or reporting
10
Your last measurement
Thursday, September 12, 13
נגטיב� לוגו
Current attempts combine hardware rather than creating a new customer experience
11
Phone + meter Meter + lancer
Thursday, September 12, 13
נגטיב� לוגו
Enter Dariowww.mydario.com
12
Thursday, September 12, 13
נגטיב� לוגו
Enter Dario13
Bulky
Cumbersome
Uninspiring
Dumb device
Compact
Simple
Beautiful
Personal data
Thursday, September 12, 13
נגטיב� לוגו
Integrated Diabetes Management System14
Smartphone-driven glucometer
Lancing device and strip container
Data management, alerts, reminders
Analytics and social interaction tools
Proactive Care capabilities
Patent-pending technology
Aligned w/stakeholders motivations
Thursday, September 12, 13
נגטיב� לוגו
Labstyle Innovations Investment Highlights15
Huge Diabetes patient population. $12bn test strips market ($37bn diabetes market, including therapeutics) with very little real innovation
Dario: First all-in-one stylish diabetes management system with glucose measurement device, data analytics, data sharing and social features
נגטיב� לוגו
נגטיב� לוגו
נגטיב� Usability and accuracy studies-לוגו-Signed UK, Belgium, Italy distribution agreements-Near term milestones:
-CE Mark expected 2013-Software launch on Appstore Q4
-Reimbursable, recurring, test strips revenue based model-expanding into a hub of solutions for Diabetics (e.g. integration with smart insulin pens; clinical studies; product market testing)
נגטיב� לוגו
Thursday, September 12, 13
נגטיב� לוגו
More than just blood glucose levels16
Blood glucose
Food Intake, Physical Activity
Insulin Recommendations
Analysis, learning, Sharing
Thursday, September 12, 13
נגטיב� לוגו
Develop a detailed understanding of your blood sugar level
17
Thursday, September 12, 13
נגטיב� לוגו
Dramatically improving information flow among patients and care givers
18
Physician Dietitian
NurseOthercare
givers
PatientREAL-TIME DATA
HISTORICAL DATA
TAILOR-MADE DATAANALYZED DATA
Thursday, September 12, 13
נגטיב� לוגו
Big Data and Proactive Care at its best19
Physician Dietitian
NurseOthercare
givers
PatientREAL-TIME DATA
HISTORICAL DATA
TAILOR-MADE DATAANALYZED DATA
•Pattern Recognition to yield personalization of Insulin Regimen
•New regimen tested in real time
•Real-Time clinical and marketing studies (Recruitment; Data capture; Analysis)
•Prediction of Diabetes complications and the need for immediate actions
Thursday, September 12, 13
נגטיב� לוגו
Community at its best- Sample applications 20
Physician Dietitian
NurseOthercare
givers
PatientREAL-TIME DATA
HISTORICAL DATA
TAILOR-MADE DATAANALYZED DATA
•User Generated Content (tips; experiences)
•Gamification
•Personalization
•Location Based Recommendations
Thursday, September 12, 13
נגטיב� לוגו
Revenue model highlights21
Combining direct to consumers and distributors model
Test strips are typically fully reimbursed; Alignment with HC Insurance Agenda
Data enables a natural expansion into insulin delivery (e.g. smart insulin pen)
Initially: Recurring, high margin revenue from sales of strips
נגטיב� לוגו
נגטיב� לוגו
נגטיב� לוגו
נגטיב� לוגו
Platform enables revenue from clinical studies and data (e.g. pharma; food)
User base enables product partnerships (e.g. pharma; food)
נגטיב� לוגו
נגטיב� לוגו
Thursday, September 12, 13
• V
22
Thursday, September 12, 13
Thursday, September 12, 13
24
Thursday, September 12, 13
Dario- Glucose Monitoring in a Fun and Engaging Way
נגטיב� לוגו
http://www.youtube.com/watch?v=he3aa34UIrI
Thursday, September 12, 13
נגטיב� לוגו
Promising regulatory outlook 2013-201426
•Anticipated 510(k) Class hardware&software
•Clarified guidelines for software / glucose meters
• In-vitro diagnostics•CE Mark anticipated 2013•Additional jurisdictions to
follow (e.g. India, Brazil)
Thursday, September 12, 13
27
Thursday, September 12, 13
נגטיב� לוגו
Experienced management team28
Oren Fuerst, PhDExecutive Chairman
Erez RaphaelCEO & President
Tal GivolyCTO
Seasoned medtech entrepreneur and investorFormer faculty Yale and Columbia Business SchoolExtensive experience in medical devices and data mgt
Former Chief Scientist of Amdocs (NYSE:DOX)25+ years in software developmentSoftware inventor with 25+ granted patents
Prof. Itamar Raz MDHead of SAB
Head of Diabetes Unit, Hadassah Medical CenterHead, Israel National Council of DiabetesPresident, Israel Diabetes Research Group
20 years of experience in product design, development and commercialization. Formerly with Amdocs (NYSE: DOX) and Nokia-Siemens
Shosh FriedmanVP Clinical and Regulatory
Affairs
Former SVP Clinical and Regulatory Affairs at Given Imaging (NASDAQ:GIVN). 20+ in clinical, regulatory affairs and QA systems.
Thursday, September 12, 13
נגטיב� לוגו
Board of Directors29
Oren Fuerst, PhDCo-Founder
Malcolm Hoenlein
Prof. Nahum Melumad PhD
Adam Stern
Seasened entrepreneur and investorFounder of Teval Global & Strategic ModelsFormer faculty Columbia Business School
CEO, Executive Vice-Chairman, Conference of Major American Jewish OrganizationsDirector, Council of Foreign Relations
Professor of Accounting and Business Law, Columbia Business SchoolConsultant to J&J, Bristol-Myers, GE
Head of Private Equity Banking at Aegis Capital and CEO of SternAegis VenturesDirector inVivo, Organovo, Prolor
David Weintraub MDCo-Founder
Co-founder, Medical Director Ramat-Aviv MCSerial entrepreneur and inventorFounder of Versamed (acquired by GE)
Itamar Raz MD Head of Diabetes Unit, Hadassah Medical CenterHead, Israel National Council of DiabetesPresident, Israel Diabetes Research Group
Thursday, September 12, 13
נגטיב� לוגו
Labstyle Innovations Investment Highlights30
Huge Diabetes patient population. $12bn test strips market ($37bn diabetes market, including therapeutics) with very little real innovation
Dario: First all-in-one stylish diabetes management system with glucose measurement device, data analytics, data sharing and social features
נגטיב� לוגו
נגטיב� לוגו
נגטיב� Usability and accuracy studies-לוגו-Signed UK, Belgium, Italy distribution agreements-Near term milestones:
-CE Mark expected 2013-Software launch on Appstore Q4
-Reimbursable, recurring, test strips revenue based model-expanding into a hub of solutions for Diabetics (e.g. integration with smart insulin pens; clinical studies; product market testing)
נגטיב� לוגו
Thursday, September 12, 13
31
Thursday, September 12, 13
Thank you
נגטיב� לוגו
Thursday, September 12, 13